These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 5862555

  • 1. The assay of Factor IX: with a note on the use of a bentonite suspension in the preparation of an artificial substrate system for Factor IX assay.
    Stapp WF.
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:109+. PubMed ID: 5862555
    [No Abstract] [Full Text] [Related]

  • 2. Performances of an artificial reagent for the one-stage factor IX assay.
    Meunier L, Allain JP, Frommel D.
    Thromb Diath Haemorrh; 1975 Jun 30; 33(3):547-52. PubMed ID: 1154311
    [Abstract] [Full Text] [Related]

  • 3. Activation of factor IX by factor XIa--a spectrophotometric assay for factor IX in human plasma.
    Tans G, Janssen-Claessen T, van Dieijen G, Hemker HC, Rosing J.
    Thromb Haemost; 1982 Oct 29; 48(2):127-32. PubMed ID: 6983739
    [Abstract] [Full Text] [Related]

  • 4. Preparation and use of a new artificial system for factor XI assay.
    Giddings JC.
    Med Lab Technol; 1971 Jul 29; 28(3):284-99. PubMed ID: 4327104
    [No Abstract] [Full Text] [Related]

  • 5. [NEW ASSAY METHOD, USING BENTONITE, OF FACTOR VII AND FACTOR X].
    MATSUOKA M, FURUTA S, MATSUOKA T, TAKAMIZAWA K, HONMA T, TAKAYAMA H.
    Naika; 1964 Mar 29; 13():549-54. PubMed ID: 14125388
    [No Abstract] [Full Text] [Related]

  • 6. In vitro thrombogenicity tests of factor IX concentrates. I. A survey of available assays.
    Prowse CV, Chirnside A, Elton RA.
    Thromb Haemost; 1980 Feb 29; 42(5):1355-67. PubMed ID: 6768149
    [Abstract] [Full Text] [Related]

  • 7. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL, Triplett DA.
    Am J Clin Pathol; 1983 Oct 29; 80(4 Suppl):633-42. PubMed ID: 6414289
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R.
    Berl Munch Tierarztl Wochenschr; 1999 Oct 29; 112(10-11):394-9. PubMed ID: 10598358
    [Abstract] [Full Text] [Related]

  • 9. [Adsorption of factors of the fibrinolytic system by bentonite].
    NIEWIAROWSKI S.
    Pathol Biol; 1959 Dec 29; 7():2557-65. PubMed ID: 14427143
    [No Abstract] [Full Text] [Related]

  • 10. [USE OF BENTONITE CLAYS IN THE PREPARATION OF OINTMENT-SUSPENSIONS AND OF THEIR CONCENTRATES].
    MURAVEV Ia, ZHAKOVA MA.
    Aptechn Delo; 1964 Dec 29; 13():23-6. PubMed ID: 14292020
    [No Abstract] [Full Text] [Related]

  • 11. Thrombogenic potential of factor IX concentrates: comparison of tests.
    Middleton SM, Forbes CD, Prentice CR.
    Thromb Haemost; 1979 Feb 15; 40(3):574-6. PubMed ID: 425073
    [No Abstract] [Full Text] [Related]

  • 12. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM.
    J Lab Clin Med; 1993 Mar 15; 121(3):394-405. PubMed ID: 8445288
    [Abstract] [Full Text] [Related]

  • 13. [The adsorption capability of beidellitic Montmorillonite].
    Brisou J.
    Med Chir Dig; 1981 Mar 15; 10(8):725-8. PubMed ID: 6279981
    [No Abstract] [Full Text] [Related]

  • 14. [Use of bentonite gel for stabilization of suspensions].
    SALO DP, CHIGRIN ZT.
    Aptechn Delo; 1963 Mar 15; 12():14-20. PubMed ID: 13991168
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models.
    Prowse CV, Williams AE.
    Thromb Haemost; 1980 Oct 31; 44(2):81-6. PubMed ID: 6779401
    [Abstract] [Full Text] [Related]

  • 16. Combined factor VIII and IX inhibitors in a girl.
    Reussi C, Altman R, Rouvier J, Maino R.
    Thromb Diath Haemorrh; 1966 Dec 01; 16(3):549-58. PubMed ID: 5996674
    [No Abstract] [Full Text] [Related]

  • 17. Substrate-dependent modulation of the mechanism of factor XIa inhibition.
    Pedicord DL, Seiffert D, Blat Y.
    Biochemistry; 2004 Sep 21; 43(37):11883-8. PubMed ID: 15362874
    [Abstract] [Full Text] [Related]

  • 18. Thrombogenicity screening of factor IX concentrates.
    Prowse CV, Pepper DS, Cash JD.
    Thromb Haemost; 1977 Oct 31; 38(3):728-9. PubMed ID: 579519
    [No Abstract] [Full Text] [Related]

  • 19. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin.
    Prowse CV, Boffa MC, Guthrie C, Pepper DS.
    Thromb Haemost; 1980 Feb 29; 42(5):1368-77. PubMed ID: 7368144
    [Abstract] [Full Text] [Related]

  • 20. Effect of electrolytes on bentonite suspensions.
    BERNSTEIN HB, BARR M.
    J Am Pharm Assoc Am Pharm Assoc; 1957 Jan 29; 46(1):41-4. PubMed ID: 13502125
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.